MaxLife review
Both headline figures are asterisked to a Starter Kit Plan that the page never describes.
The verdict
MaxLife publishes starting at $89 a month for semaglutide and $120 for tirzepatide. Both figures are asterisked to a Starter Kit Plan. The page never says what the kit is or what follows it. Fifty states are covered.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 50
- From
- From $89/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states
MaxLife sells both molecules by injection as a membership. The headline figures belong to a starter kit. Coverage is all fifty states.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The membership framing describes what is included rather than who provides it. The intake is not documented.
The asterisk is the part to read. Each headline figure is tied to a Starter Kit Plan, and the phrase appears once on each product page, in the footnote itself. What a buyer pays once the kit ends is not published.
What happens when the dose goes up?
Nothing on the product pages states what either figure does as the dose rises. Nor do they state the rate after the starter kit. Both questions belong in the intake, before the first charge.
What the price includes
$89 and $120 are starter-kit figures, not standing rates. Six months at them would be $534 and $720. That holds only if the kit runs six months, which the page does not say. The rate after the kit is not published.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Both figures shown before intake
- Strength: The asterisk sits beside each figure
- Strength: Coverage in all fifty states
- Strength: Both molecules carry a published figure
- Limitation: The kit behind the figure is undescribed
- Limitation: No milligram dose is published
- Limitation: No rate after the kit is published
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about MaxLife. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will ask what the starter kit covers and what follows it.
- Wrong for
- A reader who needs a standing monthly rate before intake.
The evidence behind what MaxLife prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How MaxLife compares
| Seller | Who it suits | Go |
|---|---|---|
 MANÜ Telehealth | Readers who want the cost of a full dose stated before starting a low one | See MANÜ Telehealth → |
 Longevixx | Readers wanting a flat rate in any state | See Longevixx → |
 LevelUp Rx | Readers who want the billed total before committing to a term | See LevelUp Rx → |
More GLP-1 telehealth sellers reviews: EdenEmbodyEnhance MDFoundGalaHealthRX
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What does the asterisk refer to?
- A Starter Kit Plan. The page names it once, in that footnote, and never describes it.
- Does the price change as my dose rises?
- Not stated on the product pages. Ask at intake, together with the rate after the kit.
- Where does tirzepatide start?
- At $120 a month, carrying the same asterisk as semaglutide.
- Is MaxLife legit?
- MaxLife is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is MaxLife expensive compared with other GLP-1 telehealth sellers?
- MaxLife publishes a starting figure of $89/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts MaxLife below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.